Twinbeech Capital LP Dyne Therapeutics, Inc. Transaction History
Twinbeech Capital LP
- $2.23 Billion
- Q3 2025
A detailed history of Twinbeech Capital LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 115,341 shares of DYN stock, worth $2.17 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
115,341
Previous 197,148
41.5%
Holding current value
$2.17 Million
Previous $1.88 Million
22.23%
% of portfolio
0.07%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
227Shares Held
148MCall Options Held
184KPut Options Held
243K-
Janus Henderson Group PLC London, X014.7MShares$278 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.76MShares$184 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$172 Million26.07% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$139 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P75.46MShares$103 Million13.81% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $975M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...